CoChat

Treatment of volumetric muscle loss in mice using nanofibrillar scaffolds enhances vascular organization and integration

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Traumatic skeletal muscle injuries cause irreversible tissue damage and impaired revascularization. Engineered muscle is promising for enhancing tissue revascularization and regeneration in injured muscle. Here we fabricated engineered skeletal muscle composed of myotubes interspersed with vascular endothelial cells using spatially patterned scaffolds that induce aligned cellular organization, and then assessed their therapeutic benefit for treatment of murine volumetric muscle loss. Murine skeletal myoblasts co-cultured with endothelial cells in aligned nanofibrillar scaffolds form endothelialized and aligned muscle with longer myotubes, more synchronized contractility, and more abundant secretion of angiogenic cytokines, compared to endothelialized engineered muscle formed from randomly-oriented scaffolds. Treatment of traumatically injured muscle with endothelialized and aligned skeletal muscle promotes the formation of highly organized myofibers and microvasculature, along with greater vascular perfusion, compared to treatment of muscle derived from randomly-oriented scaffolds. This work demonstrates the potential of endothelialized and aligned engineered skeletal muscle to promote vascular regeneration following transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-019-0416-4

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 In vitro characterization of endothelialized engineered murine muscle. Engineered skeletal muscle was formed by the fusion of murine myoblasts within randomly oriented or aligned nanofibrillar scaffolds for 9 days. Co-culture of myoblasts with endothelial cells on the scaffolds formed endothelialized engineered skeletal muscle. a, d Scanning electron microscopy images of randomly oriented (a) or aligned (d) scaffold nanofibers. b, c) Confocal microscopy images depict myosin heavy chain (MHC, green) and CD31 (magenta) staining in differentiated myotubes (b) or myotubes co-cultured with endothelial cells (c) in randomly oriented scaffolds. e, f Confocal microscopy images of MHC (green) and CD31 (magenta) of differentiated myotubes (e) or myotubes co-cultured with endothelial cells (f) on aligned scaffolds. g Average angle of orientation of differentiated myotubes, relative to the axis of aligned nanofibrils for aligned scaffolds or an arbitrary axis for randomly oriented scaffolds (n = 3 each group). h Average myotube length on either randomly oriented or aligned scaffolds cultured in the presence or absence of endothelial cells (n = 3 each group). i Myotube fusion efficiency is expressed as the average number of nuclei per myotube (n = 3 each group). j Percentage of mature striated MHC+ myotubes out of total MHC+ myotubes (n = 3 each group). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.0001 (****). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 1 μm (a, d); 100 μm (b, c)
Fig. 1 In vitro characterization of endothelialized engineered murine muscle. Engineered skeletal muscle was formed by the fusion of murine myoblasts within randomly oriented or aligned nanofibrillar scaffolds for 9 days. Co-culture of myoblasts with endothelial cells on the scaffolds formed endothelialized engineered skeletal muscle. a, d Scanning electron microscopy images of randomly oriented (a) or aligned (d) scaffold nanofibers. b, c) Confocal microscopy images depict myosin heavy chain (MHC, green) and CD31 (magenta) staining in differentiated myotubes (b) or myotubes co-cultured with endothelial cells (c) in randomly oriented scaffolds. e, f Confocal microscopy images of MHC (green) and CD31 (magenta) of differentiated myotubes (e) or myotubes co-cultured with endothelial cells (f) on aligned scaffolds. g Average angle of orientation of differentiated myotubes, relative to the axis of aligned nanofibrils for aligned scaffolds or an arbitrary axis for randomly oriented scaffolds (n = 3 each group). h Average myotube length on either randomly oriented or aligned scaffolds cultured in the presence or absence of endothelial cells (n = 3 each group). i Myotube fusion efficiency is expressed as the average number of nuclei per myotube (n = 3 each group). j Percentage of mature striated MHC+ myotubes out of total MHC+ myotubes (n = 3 each group). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.0001 (****). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 1 μm (a, d); 100 μm (b, c)CC BY · PubMed Central
Fig. 2 In vitro contraction of endothelialized engineered murine skeletal muscle. Engineered skeletal muscle (denoted as Eng Muscle) was formed by the fusion of myoblasts within randomly oriented or aligned nanofibrillar scaffolds for 9 days. Co-culture of myoblasts with endothelial cells on the scaffolds formed endothelialized engineered skeletal muscle (denoted as Endo Eng Muscle). a Colored vector plots show the magnitude and direction of representative electrically paced constructs after 9 days of culture. Shown below the colored vector plots are global movement (μm) as a function of time (s) and bright field images of engineered muscle. Scale bar denotes 500 μm. b Maximum contraction velocity (μm s–1) and (c) percentage of contracting area for engineered skeletal muscle, with or without endothelialization, formed from randomly oriented or aligned scaffolds (n ≥ 5). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***), p ≤ 0.0001 (****). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffold
Fig. 2 In vitro contraction of endothelialized engineered murine skeletal muscle. Engineered skeletal muscle (denoted as Eng Muscle) was formed by the fusion of myoblasts within randomly oriented or aligned nanofibrillar scaffolds for 9 days. Co-culture of myoblasts with endothelial cells on the scaffolds formed endothelialized engineered skeletal muscle (denoted as Endo Eng Muscle). a Colored vector plots show the magnitude and direction of representative electrically paced constructs after 9 days of culture. Shown below the colored vector plots are global movement (μm) as a function of time (s) and bright field images of engineered muscle. Scale bar denotes 500 μm. b Maximum contraction velocity (μm s–1) and (c) percentage of contracting area for engineered skeletal muscle, with or without endothelialization, formed from randomly oriented or aligned scaffolds (n ≥ 5). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***), p ≤ 0.0001 (****). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffoldCC BY · PubMed Central
Fig. 3 Secretion of angiogenic and myogenic cytokines by endothelial cells in endothelialized engineered skeletal muscle in vitro. a Representative proteomic array depicts the protein expression of differentially expressed cytokines secreted by endothelial cells when co-seeded with myoblasts in randomly oriented or aligned scaffolds for 6 or 9 days of culture. Highlighted in red are (1) angiogenin, (2) insulin-like growth factor binding protein-3 (IGFBP-3), and (3) vascular endothelial growth factor (VEGF) in replicate samples. Inset shows representative replicate spots depicting secreted VEGF levels. b Relative fold change in the protein expression of angiogenin, IGFBP-3, and VEGF compared with randomly oriented constructs after 6 days of culture (n ≥ 3 each group). c Fold change difference in nitric oxide based on the fluorescence intensity of nitric oxide fluorescent probe in the presence of axitinib, a small molecule inhibitor of VEGF receptor. Samples consist of endothelial cells co-cultured with myoblasts in randomly oriented and aligned skeletal muscle constructs for 6 days of culture (n ≥ 3 each group). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***), p ≤ 0.0001 (****). Error bars represent standard deviation
Fig. 3 Secretion of angiogenic and myogenic cytokines by endothelial cells in endothelialized engineered skeletal muscle in vitro. a Representative proteomic array depicts the protein expression of differentially expressed cytokines secreted by endothelial cells when co-seeded with myoblasts in randomly oriented or aligned scaffolds for 6 or 9 days of culture. Highlighted in red are (1) angiogenin, (2) insulin-like growth factor binding protein-3 (IGFBP-3), and (3) vascular endothelial growth factor (VEGF) in replicate samples. Inset shows representative replicate spots depicting secreted VEGF levels. b Relative fold change in the protein expression of angiogenin, IGFBP-3, and VEGF compared with randomly oriented constructs after 6 days of culture (n ≥ 3 each group). c Fold change difference in nitric oxide based on the fluorescence intensity of nitric oxide fluorescent probe in the presence of axitinib, a small molecule inhibitor of VEGF receptor. Samples consist of endothelial cells co-cultured with myoblasts in randomly oriented and aligned skeletal muscle constructs for 6 days of culture (n ≥ 3 each group). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***), p ≤ 0.0001 (****). Error bars represent standard deviationCC BY · PubMed Central
Fig. 4 Global gene expression profiles of endothelialized engineered muscle derived from randomly oriented or aligned scaffolds. a Heat map of the top 500 differentially expressed genes by engineered muscle or endothelialized engineered muscle grown in randomly oriented (random) or aligned scaffolds (false discovery rate q-value < 0.05). b Gene Set Enrichment Analysis shows selected gene ontology data sets enriched in the endothelialized engineered muscle derived from aligned scaffolds, in comparison with randomly oriented scaffolds. Gene ontology data sets are shown for myogenesis, oxidative phosphorylation, and tumor necrosis factor-α (TNFA) via nuclear factor κ-light-chain-enhancer of activated B cells (NKFB)
Fig. 4 Global gene expression profiles of endothelialized engineered muscle derived from randomly oriented or aligned scaffolds. a Heat map of the top 500 differentially expressed genes by engineered muscle or endothelialized engineered muscle grown in randomly oriented (random) or aligned scaffolds (false discovery rate q-value < 0.05). b Gene Set Enrichment Analysis shows selected gene ontology data sets enriched in the endothelialized engineered muscle derived from aligned scaffolds, in comparison with randomly oriented scaffolds. Gene ontology data sets are shown for myogenesis, oxidative phosphorylation, and tumor necrosis factor-α (TNFA) via nuclear factor κ-light-chain-enhancer of activated B cells (NKFB)CC BY · PubMed Central
Fig. 5 Bioluminescence imaging of donor mouse myoblast survival in a murine model of volumetric muscle loss. a Representative bioluminescence images of bioluminescently labeled myoblasts within endothelialized engineered skeletal muscle formed from randomly oriented or aligned scaffolds. b Quantitative analysis is shown of the bioluminescence signal on days 1, 7, 14, and 21 days after transplantation into the ablated muscle of mice (*p ≤ 0.05) compared with all other groups (n = 4). Error bars represent standard deviation. Scale bar denotes 1 cm
Fig. 5 Bioluminescence imaging of donor mouse myoblast survival in a murine model of volumetric muscle loss. a Representative bioluminescence images of bioluminescently labeled myoblasts within endothelialized engineered skeletal muscle formed from randomly oriented or aligned scaffolds. b Quantitative analysis is shown of the bioluminescence signal on days 1, 7, 14, and 21 days after transplantation into the ablated muscle of mice (*p ≤ 0.05) compared with all other groups (n = 4). Error bars represent standard deviation. Scale bar denotes 1 cmCC BY · PubMed Central
Fig. 6 Implantation of murine engineered skeletal muscle in a mouse model of volumetric muscle loss. a Longitudinal sections of endothelialized engineered muscle formed randomly oriented or aligned skeletal muscle constructs. Donor transplanted myofibers are denoted by the co-expression of green fluorescence protein (GFP, green) and myosin heavy chain (MHC, red). Native myofibers are denoted by MHC+/GFP- expression. Insets show higher magnification images of the GFP+ region depicted by white boxes in the center of the engineered tissues. b Representative image of a tissue cross-section of muscle transplanted with an endothelialized engineered skeletal muscle construct at 21 days after induction of traumatic muscle injury. MHC (red) indicates mature myofibers, GFP (green) indicates the transplanted myoblast population, and nuclei are visualized in blue using Hoechst 33342 dye. c The density of MHC+/GFP+ transplanted myofibers in the region of regeneration is shown (n ≥ 3, **p ≤ 0.01). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 50 μm (inset) or 500 μm (a); 500 μm (b)
Fig. 6 Implantation of murine engineered skeletal muscle in a mouse model of volumetric muscle loss. a Longitudinal sections of endothelialized engineered muscle formed randomly oriented or aligned skeletal muscle constructs. Donor transplanted myofibers are denoted by the co-expression of green fluorescence protein (GFP, green) and myosin heavy chain (MHC, red). Native myofibers are denoted by MHC+/GFP- expression. Insets show higher magnification images of the GFP+ region depicted by white boxes in the center of the engineered tissues. b Representative image of a tissue cross-section of muscle transplanted with an endothelialized engineered skeletal muscle construct at 21 days after induction of traumatic muscle injury. MHC (red) indicates mature myofibers, GFP (green) indicates the transplanted myoblast population, and nuclei are visualized in blue using Hoechst 33342 dye. c The density of MHC+/GFP+ transplanted myofibers in the region of regeneration is shown (n ≥ 3, **p ≤ 0.01). Error bars represent standard deviation. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 50 μm (inset) or 500 μm (a); 500 μm (b)CC BY · PubMed Central
Fig. 7 Murine endothelialized engineered skeletal muscle promotes vascular anastomosis and revascularization in a mouse model of volumetric muscle loss. a Representative confocal microscopy images of perfused vasculature from transverse tissue sections in the region of regeneration adjacent to the endothelialized randomly oriented or endothelialized aligned transplanted skeletal muscle constructs at 21 days after implantation. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). b Perfused vessel density in the region of regeneration (n ≥ 4, **p ≤ 0.01). Dotted line denotes the levels of the acellular scaffold control. c Bioluminescence imaging of randomly oriented or aligned skeletal muscle constructs seeded with bioluminescent endothelial cells transplanted into ablated muscle. d Perfused vessel organization within transplanted endothelialized engineered muscle formed from randomly oriented or aligned scaffolds. Inset shows the arrangement of myofibers and the associated vessel architecture as visualized by green fluorescence protein (GFP) expression (turquois) in the transplanted myofibers and fluorescently labeled isolectin (red). Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 100 μm (a), 1 cm (c), and 50 μm (d). Error bars represent standard deviation
Fig. 7 Murine endothelialized engineered skeletal muscle promotes vascular anastomosis and revascularization in a mouse model of volumetric muscle loss. a Representative confocal microscopy images of perfused vasculature from transverse tissue sections in the region of regeneration adjacent to the endothelialized randomly oriented or endothelialized aligned transplanted skeletal muscle constructs at 21 days after implantation. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). b Perfused vessel density in the region of regeneration (n ≥ 4, **p ≤ 0.01). Dotted line denotes the levels of the acellular scaffold control. c Bioluminescence imaging of randomly oriented or aligned skeletal muscle constructs seeded with bioluminescent endothelial cells transplanted into ablated muscle. d Perfused vessel organization within transplanted endothelialized engineered muscle formed from randomly oriented or aligned scaffolds. Inset shows the arrangement of myofibers and the associated vessel architecture as visualized by green fluorescence protein (GFP) expression (turquois) in the transplanted myofibers and fluorescently labeled isolectin (red). Arrow designates orientation of aligned nanofibrillar scaffold. Scale bars denote 100 μm (a), 1 cm (c), and 50 μm (d). Error bars represent standard deviationCC BY · PubMed Central
Fig. 8 Murine endothelialized engineered skeletal muscle supports the formation of organized vascular networks in traumatically injured muscle. a Representative confocal microscopy images of perfused vasculature from longitudinal tissue sections in the region of regeneration adjacent to the endothelialized randomly oriented or endothelialized aligned transplanted skeletal muscle constructs at 21 days after implantation. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). Insets are higher magnification images of the center of the engineered tissues as depicted by white boxes. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bar (inset) denotes 100 μm, Scale bar denotes 500 μm. b Anisotropy is used to quantify the directional dependence towards the formation of parallel-aligned vascular networks. A value approaching zero corresponds to unrestricted (non-patterned) paths, whereas a value approaching one denotes restriction to one axis to form a parallel-aligned spatial pattern (n = 4). Inset shows representative frequency plots generated by two-dimensional Fast Fourier Transform analysis, in which random orientation of vascular networks are depicted as pixels evenly distributed about the central origin, whereas parallel alignment of vascular networks is depicted as pixels preferentially organized along a single axes (vertical). Quantification of engineered muscle (Eng Muscle) and endothelialized engineered muscle (Endothelialized Eng Muscle) treatment groups is shown. c Global angle of alignment of vascular networks was quantified as the angle formed by the relative orientation of the vascular networks, relative to the axis of the aligned nanofibrils. A degree of alignment of 0 depicts parallel alignment of vascular networks to the aligned nanofibrils. For randomly oriented scaffolds, an arbitrary axis is used (n = 4). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**). Error bars represent standard deviation
Fig. 8 Murine endothelialized engineered skeletal muscle supports the formation of organized vascular networks in traumatically injured muscle. a Representative confocal microscopy images of perfused vasculature from longitudinal tissue sections in the region of regeneration adjacent to the endothelialized randomly oriented or endothelialized aligned transplanted skeletal muscle constructs at 21 days after implantation. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). Insets are higher magnification images of the center of the engineered tissues as depicted by white boxes. Arrow designates orientation of aligned nanofibrillar scaffold. Scale bar (inset) denotes 100 μm, Scale bar denotes 500 μm. b Anisotropy is used to quantify the directional dependence towards the formation of parallel-aligned vascular networks. A value approaching zero corresponds to unrestricted (non-patterned) paths, whereas a value approaching one denotes restriction to one axis to form a parallel-aligned spatial pattern (n = 4). Inset shows representative frequency plots generated by two-dimensional Fast Fourier Transform analysis, in which random orientation of vascular networks are depicted as pixels evenly distributed about the central origin, whereas parallel alignment of vascular networks is depicted as pixels preferentially organized along a single axes (vertical). Quantification of engineered muscle (Eng Muscle) and endothelialized engineered muscle (Endothelialized Eng Muscle) treatment groups is shown. c Global angle of alignment of vascular networks was quantified as the angle formed by the relative orientation of the vascular networks, relative to the axis of the aligned nanofibrils. A degree of alignment of 0 depicts parallel alignment of vascular networks to the aligned nanofibrils. For randomly oriented scaffolds, an arbitrary axis is used (n = 4). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**). Error bars represent standard deviationCC BY · PubMed Central
Fig. 9 Transplantation of human endothelialized skeletal muscle into traumatically injured muscle. Human endothelialized skeletal muscle bundles were composed of primary human cells. a Representative confocal microscopy images of perfused vasculature in the region of regeneration adjacent to endothelialized muscle formed from randomly oriented or aligned scaffolds are shown. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). b Perfused vessel density adjacent to the site of engineered muscle transplantation (n = 3). c Representative image of donor-derived myofibers in the region of regeneration adjacent to endothelialized muscle formed from randomly oriented or aligned scaffolds. Donor-derived myofibers are identified by the dual co-expression of human nuclear antigen (HNA, yellow) and myosin heavy chain (MHC, red). Arrows denote native myofibers and arrowheads denote donor-derived myofibers. d The density of donor-derived (HNA+/MHC+) myofibers in the region of regeneration is shown (n = 6). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**). Error bars represent standard deviation. Scale bars denote 100 μm (a); 150 μm (c)
Fig. 9 Transplantation of human endothelialized skeletal muscle into traumatically injured muscle. Human endothelialized skeletal muscle bundles were composed of primary human cells. a Representative confocal microscopy images of perfused vasculature in the region of regeneration adjacent to endothelialized muscle formed from randomly oriented or aligned scaffolds are shown. Endothelial cells are identified by CD31 (red) expression. Perfused vessels are indicated by co-expression of CD31 (red) and fluorescently labeled isolectin (turquois). b Perfused vessel density adjacent to the site of engineered muscle transplantation (n = 3). c Representative image of donor-derived myofibers in the region of regeneration adjacent to endothelialized muscle formed from randomly oriented or aligned scaffolds. Donor-derived myofibers are identified by the dual co-expression of human nuclear antigen (HNA, yellow) and myosin heavy chain (MHC, red). Arrows denote native myofibers and arrowheads denote donor-derived myofibers. d The density of donor-derived (HNA+/MHC+) myofibers in the region of regeneration is shown (n = 6). For indicated comparisons: p ≤ 0.05 (*), p ≤ 0.01 (**). Error bars represent standard deviation. Scale bars denote 100 μm (a); 150 μm (c)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. Simmons, C. S. Mechanical Stimulation and Non-Destructive Functional Assessment of Cardiovascular Cells In Vitro. https://purl.stanford.edu/jm601xh1638 Thesis (Ph.D.), Stanford University (2013).

Metadata

Authors
Nakayama, K. H., Quarta, M., Paine, P., Alcazar, C., Karakikes, I., Garcia, V., Abilez, O. J., Calvo, N. S., Simmons, C. S., Rando, T. A., & Huang, N. F.
Affiliations
  • VA Palo Alto Health Care System (US)
  • Stanford Cardiovascular Institute (US)
  • University of Florida (US)
Corresponding author
Huang, Ngan F.
Venue
Communications Biology
Published
2019-05-07
Volume
2
Issue
1
Pages
170-170
ISSN
2399-3642 (ISSN-L)
OpenAlex
W2944633430
Cited by
113
References
60
Citations by year
2026: 9 · 2025: 18 · 2024: 21 · 2023: 13 · 2022: 13 · 2021: 21 · 2020: 15 · 2019: 3
FWCI
12.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (R01 HL127113, R01 HL142718, P2CHD086843,, K99 HL136701, P01 AG036695)
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
volumetric muscle loss, engineered skeletal muscle, vascular endothelial cells, myotubes, muscle regeneration, endothelialization, angiogenic cytokines, microcirculation, muscle transplantation, traumatic muscle injury
MeSH terms
Animals, Cell Line, Humans, Regeneration, Cytokines, Muscle, Skeletal, Muscle Fibers, Skeletal, Coculture Techniques, Tissue Engineering, Myoblasts, Skeletal, Endothelial Cells, Mice, Tissue Scaffolds, Nanofibers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of volumetric muscle loss in mice using nanofibrillar scaffolds enhances vascular organization and integration. https://app.cochat.ai/papers/10.1038/s42003-019-0416-4
The paper
Nakayama, K. H., Quarta, M., Paine, P., Alcazar, C., Karakikes, I., Garcia, V., Abilez, O. J., Calvo, N. S., Simmons, C. S., Rando, T. A., & Huang, N. F. (2019). Treatment of volumetric muscle loss in mice using nanofibrillar scaffolds enhances vascular organization and integration. Communications Biology. https://doi.org/10.1038/s42003-019-0416-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.